Retrieve available abstracts of 22 articles: HTML format
Single Articles
April 2025
HEGELE RA What is the phenotype of heterozygous lipoprotein lipase deficiency?
Curr Opin Lipidol. 2025;36:96-103. PubMedAbstract available
March 2025
ALNOURI F, Raal FJ Familial hypercholesterolemia in pregnancy.
Curr Opin Lipidol. 2025 Mar 7. doi: 10.1097/MOL.0000000000000980. PubMedAbstract available
December 2024
TAMEHRI ZADEH SS, Pang J, Chan DC, Watts GF, et al A contemporary snapshot of familial hypercholesterolemia registries.
Curr Opin Lipidol. 2024;35:297-302. PubMedAbstract available
November 2024
BIRKENHEAD K, Sullivan D, Watts GF, Sarkies MN, et al Implementation science and genetic testing for familial hypercholesterolemia.
Curr Opin Lipidol. 2024 Nov 26. doi: 10.1097/MOL.0000000000000967. PubMedAbstract available
PAQUETTE M, Guay SP, Baass A Genetic determinants of pancreatitis risk in hypertriglyceridemia.
Curr Opin Lipidol. 2024 Nov 11. doi: 10.1097/MOL.0000000000000962. PubMedAbstract available
September 2024
RAMASWAMI U, Priestley-Barnham L, Humphries SE Universal screening for familial hypercholesterolaemia: how can we maximise
benefits and minimise potential harm for children and their families.
Curr Opin Lipidol. 2024 Sep 27. doi: 10.1097/MOL.0000000000000952. PubMedAbstract available
June 2024
BASHIR B, Ferdousi M, Durrington PN, Soran H, et al Pancreatic and cardiometabolic complications of severe hypertriglyceridaemia.
Curr Opin Lipidol. 2024 Jun 7. doi: 10.1097/MOL.0000000000000939. PubMedAbstract available
April 2024
BRUNHAM LR Familial hypercholesterolemia-Plus: is the metabolic syndrome changing the
clinical picture of familial hypercholesterolemia?
Curr Opin Lipidol. 2024 Apr 22. doi: 10.1097/MOL.0000000000000938. PubMedAbstract available
CIVEIRA F, Martin C, Cenarro A APOE and familial hypercholesterolemia.
Curr Opin Lipidol. 2024 Apr 17. doi: 10.1097/MOL.0000000000000937. PubMedAbstract available
February 2024
CHAN DC, Watts GF ANGPTL3 and ApoC-III inhibitors for treating hypertriglyceridemia in context:
horses for courses?
Curr Opin Lipidol. 2024 Feb 20. doi: 10.1097/MOL.0000000000000920. PubMedAbstract available
VAN DEN BOSCH SE, Hutten BA, Corpeleijn WE, Kusters DM, et al Familial hypercholesterolemia in children and the importance of early treatment.
Curr Opin Lipidol. 2024 Feb 15. doi: 10.1097/MOL.0000000000000926. PubMedAbstract available
ZHANG Y, de Ferranti SD, Moran AE Genetic testing for familial hypercholesterolemia.
Curr Opin Lipidol. 2024 Feb 1. doi: 10.1097/MOL.0000000000000925. PubMedAbstract available
December 2023
PERERA SD, Hegele RA Genetic variation in apolipoprotein A-V in hypertriglyceridemia.
Curr Opin Lipidol. 2023 Dec 21. doi: 10.1097/MOL.0000000000000916. PubMedAbstract available
ROMERO-JIMENEZ MJ, Mansilla-Rodriguez ME, Gutierrez-Cortizo EN Predictors of cardiovascular risk in familial hypercholesterolemia.
Curr Opin Lipidol. 2023;34:272-277. PubMedAbstract available
GILLARD BK, Rosales C, Gotto AM Jr, Pownall HJ, et al The pathophysiology of excess plasma-free cholesterol.
Curr Opin Lipidol. 2023;34:278-286. PubMedAbstract available
KARALIS DG Strategies of improving adherence to lipid-lowering therapy in patients with
atherosclerotic cardiovascular disease.
Curr Opin Lipidol. 2023;34:252-258. PubMedAbstract available
November 2023
ROY G, Drouin-Chartier JP Cardiovascular disease prevention in heterozygous familial hypercholesterolemia:
how important is a healthy diet in the era of long-lasting cholesterol-lowering
drug therapies?
Curr Opin Lipidol. 2023 Nov 2. doi: 10.1097/MOL.0000000000000908. PubMedAbstract available
August 2023
CHOUDHARI P, Patni N Updates in the management of pediatric dyslipidemia.
Curr Opin Lipidol. 2023;34:156-161. PubMedAbstract available
June 2023
GANDA OP Triglyceride-rich lipoproteins, remnant-cholesterol, and atherosclerotic
cardiovascular disease.
Curr Opin Lipidol. 2023;34:105-113. PubMedAbstract available
WADSTROM BN, Pedersen KM, Wulff AB, Nordestgaard BG, et al Inflammation compared to low-density lipoprotein cholesterol: two different
causes of atherosclerotic cardiovascular disease.
Curr Opin Lipidol. 2023;34:96-104. PubMedAbstract available
April 2023
CLARKE SL Does low-density lipoprotein fully explain atherosclerotic risk in familial
hypercholesterolemia?
Curr Opin Lipidol. 2023;34:52-58. PubMedAbstract available
March 2023
VUORIO A, Raal F, Kovanen PT Familial hypercholesterolemia: The nexus of endothelial dysfunction and
lipoprotein metabolism in COVID-19.
Curr Opin Lipidol. 2023 Mar 10. doi: 10.1097/MOL.0000000000000876. PubMedAbstract available